Market Indices
Latest News
 |
Key Points- Robbins LLP reminds investors of the lead plaintiff deadline...March 17, 2026 TCOM 0.33% |
| ||
| ||
| ||
|
Price Targets
Ellie Jiang from Macquarie issued a price target of $10.70 for TME on 2026-03-17 18:46:00.The adjusted price target was set to $10.70.At the time of the announcement, TME...
March 17, 2026 TME -24.72%
Greg Renza from Truist Financial issued a price target of $8.00 for BCYC on 2026-03-17 15:51:00.The adjusted price target was set to $8.00.At the time of the announcement,
March 17, 2026 BCYC 0.89%
Thomas Chong from Jefferies issued a price target of $23.00 for TME on 2026-03-17 14:41:00.The adjusted price target was set to $23.00.At the time of the announcement, TME...
March 17, 2026 TME -24.72%
Maxwell Skor from Morgan Stanley issued a price target of $13.00 for BCYC on 2026-03-17 12:29:00.The adjusted price target was set to $13.00.At the time of the announcement,
March 17, 2026 BCYC 0.89%
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT -2.01%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA 2.19%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 CUK 1.64%